Tue, Dec 19, 2023
Stocks of diagnostic test providers such as Dr Lal Pathlabs and Thyrocare were in demand on Tuesday after the government issued guidelines in connection with a new variant of COVID-19 amid an uptick in cases in some parts of the country.
More >
Mon, Jun 28, 2021
Thyrocare Technologies Limited's Promoter and Chairman and Managing Director (CMD) A Velumani has sold over 66 percent of his stake to online healthcare start-up PharmEasy for Rs 4,546 cr. In an exclusive interview with Anil Singhvi, Managing Editor at Zee Business, Velumani talks about this move and why he has a unique strength in decision making.
Online healthcare start-up PharmEasy has announced its acquisition of Thyrocare Technologies, an established diagnostics business. Speaking on the valuation and the deal Anil Singhvi, Managing Editor at Zee Business said that this acquisition is very interesting.
Sat, Jun 26, 2021
In a significant development, digital healthcare company Pharmeasy on Friday announced that it will acquire a controlling stake in diagnostic chain Thyrocare for Rs 4,546 crore.
Wed, Jan 13, 2021
Dr. A. Velumani, Chairman & Managing Director (CMD), Thyrocare, talks about the COVID vaccine distribution play, Union Budget and expectations from it, expected growth in next 10 years and expansion plans during an interview with Swati Khandelwal, Zee Business.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
